Inmune Bio (INMB) Retained Earnings (2017 - 2026)
Inmune Bio (INMB) posted Retained Earnings of -$727000.0 for Q1 2026, up 1.36% sequentially from -$737000.0 in Q4 2025, and down 100.36% YoY from $203.1 million in Q1 2025.
Inmune Bio (INMB) Retained Earnings (2017 - 2026) Analysis & Trends
Inmune Bio has reported Retained Earnings for 10 years, with the latest figure at -$727000.0 in Q1 2026.
- Quarterly Retained Earnings fell 100.36% year-over-year to -$727000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$727000.0 (down 100.36% YoY) and the FY2025 annual result came in at -$737000.0, down 100.38% from the prior year.
- Retained Earnings rose to -$727000.0 in Q1 2026 per INMB's latest filing, from -$737000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $229.9 million in Q3 2025 and troughed at -$141.8 million in Q2 2024.
- A 5-year average of $65.7 million and a median of $146.2 million in 2022 frame the typical range for Retained Earnings.
- The widest YoY moves for Retained Earnings: up 1218116.67% in 2022, down 9101500.0% in 2022.
- Over 5 years, Retained Earnings stood at -$91.0 million in 2022, then jumped by 274.86% to $159.1 million in 2023, then advanced by 23.01% to $195.8 million in 2024, then sank by 100.38% to -$737000.0 in 2025, then grew by 1.36% to -$727000.0 in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$727000.0, -$737000.0, and $229.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Inmune Bio | 61.59 Mn | 43.18 Mn | - | 237.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 237.69 Mn |
| Mar 31, 2026 | -727,000.00 |
| Dec 31, 2025 | -737,000.00 |
| Sep 30, 2025 | 229.89 Mn |
| Jun 30, 2025 | 226.90 Mn |
| Mar 31, 2025 | 203.10 Mn |
| Dec 31, 2024 | 195.75 Mn |
| Sep 30, 2024 | 193.58 Mn |
| Jun 30, 2024 | -141.79 Mn |
| Mar 31, 2024 | -132.05 Mn |
| Dec 31, 2023 | 159.14 Mn |
| Sep 30, 2023 | 157.26 Mn |
| Jun 30, 2023 | 155.40 Mn |
| Mar 31, 2023 | -97.55 Mn |
| Dec 31, 2022 | -91.01 Mn |
| Sep 30, 2022 | -85.18 Mn |
| Jun 30, 2022 | -701,000.00 |
| Mar 31, 2022 | 146.19 Mn |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | -54.04 Mn |